Chronic myeloid leukaemia in the South African public health setting: Are we reaching the European LeukemiaNet targets for frontline therapy?

South African Journal of Oncology

Gina Joubert¹  Christopher D. Viljoen²  Shivani Dhar³  Jacques L.R. Malherbe³  Claire L. Barrett³  Tshifhiwa B. Sikhipha³ 

[1] Department of Biostatistics, Faculty of Health Sciences, University of the Free State, Bloemfontein;Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein;Department of Internal Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein;

关键词: chronic myeloid leukemia;    cml;    outcomes;    frontline therapy;    tyrosine kinase inhibitors;    imatinib;   

DOI  :  10.4102/sajo.v4i0.158

来源: DOAJ

【 授权许可】

Unknown